Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Koppert Biological Systems is a private Dutch agricultural biotechnology company focused on biological crop protection, natural pollination, and plant health solutions for professional agriculture and horticulture. Founded in 1967, the company develops and commercializes natural enemies, beneficial microorganisms, bumblebee-based pollination systems, monitoring tools, and application services that help reduce chemical pesticide use. Koppert operates globally, serving growers in more than 100 countries with a portfolio of over 300 solutions. Its business is centered on integrated pest management and sustainable cultivation rather than human therapeutics, but it is clearly part of the broader life sciences and biotechnology ecosystem. The company has expanded internationally through acquisitions and local production facilities, including operations in the Netherlands, Spain, Brazil, Mexico, and the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Koppert Biological Systems.